Thimerosal and vaccines - A cautionary tale

New England Journal of Medicine

Volumn 357, Issue 13, 2007, Pages 1278-1279

  Offit, Paul A ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; EDETIC ACID; ETHYLMERCURY DERIVATIVE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; INFLUENZA VACCINE; MERCURY DERIVATIVE; METHYLMERCURY; THIOMERSAL; VACCINE;

AUTISM; CHILD HEALTH CARE; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HUMAN; MENTAL DISEASE; NEUROLOGIC DISEASE; POLITICS; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES; VACCINATION;

EID: 34748863496     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp078187     Document Type: Article

References (4)

1. 21 USC 397 Section 413, 1997.
2. Stratton K, Gable A, McCormick MC, eds. Immunization safety review: thimerosal-containing vaccines and neurodevelopmental disorders. Washington, DC: National Academy Press, 2001.
3. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep 1999;48:563-65.
4. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 2004;114: 793-804. [Erratum, Pediatrics 2005;115:200.]